Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AB, Abilify, Absent, addressing, adefovir, adjunctive, Agglomerated, aggressive, Alkeran, Almirall, amiodarone, antibody, antifungal, antiplatelet, antipsychotic, API, araC, arose, assistance, AstraZeneca, Biodesign, Biovitrum, bisulfate, borrowed, brand, BVF, canine, captisol, carcinoma, carfilzomib, catastrophic, CDK, Cerenia, China, Chinese, Chiva, clopidogrel, complicated, concurrent, contemplated, contraceptive, contraindicated, coordinating, Cork, cyclodextrin, cydex, cytarabine, damage, deplete, developmental, Diagnostic, dipivoxil, dissolved, dissolving, DMF, dosage, doubt, epilepsy, erosion, establishedin, Euro, exacerbated, expcted, expedited, fact, family, FarmaCiencia, fast, faster, fifty, figure, fire, Fosphenytoin, GBG, Genaera, Geodon, grossed, growing, HCC, HCV, hepatitic, hepatocellular, HepB, HepC, Hepsera, Hovione, illustrated, IM, incapacitated, incomplete, infusion, ingredient, intention, interleukin, intermediate, intervention, intramuscular, JNK, judgement, JVR, kidney, KU, Labour, lamattina, lean, lender, Lisbon, Macau, main, majeure, MedImmune, melanoma, melphalan, merit, metabolite, midst, migraine, Ministry, missing, monetary, monotherapy, morphology, myeloma, nausea, Nexterone, noncommercial, notified, novation, onset, Onyx, opportunity, Orange, orphan, outlicensed, outlicensing, outsource, overcome, palliative, PCI, perception, Pharmaceuticalsfor, Pharmascience, PLAVIX, PMEA, Poltack, Portuguese, Prism, prohibited, prohibitively, propylene, Proteolix, Proximagen, purity, qualification, reconstitution, reformulation, refractory, replication, reverted, Roberson, rolling, SA, saline, SCH, simple, simultaneously, sixty, solid, solubility, solution, solvency, solvent, spectrum, spent, splenectomized, split, sterility, steroid, strict, strong, structure, sued, supplier, Swedish, Tanaproget, tartrate, thought, today, Topamax, topiramate, tornado, transplant, tumor, twenty, uncured, undergone, undisclosed, unexpected, unpredictable, unsuitable, unusually, unwilling, upcoming, Valude, vast, Venenum, vfend, voriconazole, vulnerable, wave, Welfare, zone
Removed:
Abbott, abuse, adriamycin, advancing, advisory, AG, aim, al, Alexander, alleged, amounting, appeal, approvable, approximate, approximation, Aprela, Aranesp, assay, Avenue, Bailment, Baker, Bank, banking, Barney, billion, Biopharmaceutique, Bioventure, Boston, Bristol, broader, build, built, call, Canadian, cancer, Cassidy, Chancery, Chase, Chen, collect, combine, Commonwealth, communication, conform, convene, convenience, cooperate, counsel, Crane, decision, declaratory, departing, deposited, desired, detailing, dismissal, Dorsey, Dr, drawn, Du, Dziewanowska, EITF, element, Eli, employed, employment, enforcement, enrichment, EPO, Eprex, escrowed, estimable, exclusively, Execchoice, exploit, exposed, field, FIN, Financiere, formal, functional, GAAP, Gerald, Grand, guide, Hematology, Hirsch, hot, ifosfamide, Imperial, incidence, informed, infrastructure, Innovatech, insignificance, Institutional, interim, Jean, Josefsen, JP, Kft, Knight, leader, led, Lehman, Leon, Lilly, loaned, Lockup, Loretta, lp, Ltee, MAA, Maier, Marathon, marrow, Martin, Master, Meglasson, menopausal, meruit, metabolic, mimetic, modern, molecular, Montreal, Morgan, negotiation, noncontrolling, Nonqualified, noted, obesity, Offshore, Oliver, opioid, oppose, Ordinary, organization, Pacific, par, Pasteur, Paul, penetration, placebo, Pledge, pledged, PREMARIN, Procrit, Promissory, promote, quantum, ratably, recombinant, recover, red, Reed, refunded, regimen, relief, Reorganization, repaid, repay, retail, reviewing, revised, Robert, Robinson, Royal, secured, Seidman, Separation, sharing, Shoreline, showed, smaller, Smith, Societe, Sofinov, stiffer, studied, substantially, Surgical, symptomatic, targeted, testosterone, thirty, Tod, toSergio, translation, Turi, ultra, unconditional, unjust, unknown, USL, variable, Venture, Whitney, wholesale, wind, Zofia
Filing tables
Filing exhibits
- 10-K Annual report
- 10.100 Captisol Supply Agreement
- 10.101 1ST Amendment to Captisol Supply Agreement
- 10.102 2ND Amendment to Captisol Supply Agreement
- 10.103 3RD Amendment to Captisol Supply Agreement
- 10.104 4TH Amendment to Captisol Supply Agreement
- 10.105 License Agreement
- 10.106 First Amendment to License Agreement
- 10.107 Second Amendment to License Agreement
- 10.108 Exclusive License Agreement
- 10.109 Nonexclusive License Agreement
- 10.110 Addendum to Nonexclusive License Agreement
- 10.111 Acknowledgement Agreement
- 10.112 License Agreement
- 10.113 Amendment to License Agreement
- 10.114 Supply Agreement
- 21.1 Subsidiaries of Registrant
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification by Principal Executive Officer
- 31.2 Certification by Principal Financial Officer
- 32.1 Certification by Principal Executive Officer
- 32.2 Certification by Principal Financial Officer
Related press release
LGND similar filings
Filing view
External links
Exhibit 21.1
LIGAND PHARMACEUTICALS INCORPORATED
LIST OF SUBSIDIARIES
Name | Jurisdiction of Incorporation | |
Glycomed Incorporated | California | |
Allergan Ligand Retinoid Therapeutics, Inc. | Delaware | |
Ligand Pharmaceuticals International, Inc. | Delaware | |
Ligand JVR, Inc. | Delaware | |
Seragen Incorporated | Delaware | |
Seragen Technology, Inc. | Delaware | |
Pharmacopeia, LLC | Delaware | |
Metabasis Therapeutics, Inc. | Delaware | |
Neurogen Corporation | Delaware | |
CyDex Pharmaceuticals, Inc. | Delaware |